Arizona’s statewide life science and healthcare industry association unveils plans for 2019 and announces new grant funding to accelerate the process.Continue reading
Author Archive: AZBio
Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors
- Roche collaborates with Merck to develop companion diagnostic for use with Keytruda (pembrolizumab), Merck’s anti-PD-1 therapy, in advanced solid tumors with mismatch repair deficiency (dMMR)
- Roche will seek FDA approval for biomarker panel expected to provide a standardized predictive testing option for dMMR
UA Chemical Biologists Unearth Cause of a Rare Brain Disorder
In pontocerebellar hypoplasia type 1b, two key biological structures are blocked from binding to one another — which ultimately stunts critical brain growth.Continue reading
Precision medicine collaborations to continue through Flinn seed-grants program
Seven research partnerships between Arizona biomedical scientists and clinicians are being funded through a Flinn Foundation program to advance the state’s growing niche in precision medicine.Continue reading
Arizona Bioindustry Association receives grant from the U.S. Economic Development Administration to Support Building an Evergreen Seed Fund for Arizona-based Health Innovations
CHANDLER, Ariz — (BUSINESS WIRE) — The Arizona Bioindustry Association (AZBio) today announced that it has been awarded a $299,750 grant from the U.S. Economic Development Administration’s (EDA) 2018 Regional Innovation Strategies (RIS) program competition to support the creation of a sustainable seed fund for life science innovation in Arizona. In addition to the federal contribution to the project, AZBio and its partners will provide matching support in excess of $500,000 over the three-year term of the project. These resources support the seed fund capital campaign, structure and operations as well as programs designed to help Arizona life science companies prepare for the investment process. Neither the federal funds or the matching funds may be used to capitalize the fund itself or for direct investment into individual companies.Continue reading
U.S. Food and Drug Administration Awards Contract to Critical Path Institute for Kidney Transplant Database
Patient-level data will inform the creation of drug development tools and speed development of new immunosuppressive treatmentsContinue reading
HonorHealth to Advance Heart and Vascular Services With Funding From The Bob & Renee Parsons Foundation
The Bob & Renee Parsons Foundation has issued a $500,000 matching grant to aid HonorHealth in its expansion of the heart and vascular services offered at the HonorHealth Shea Medical Center. The new Bob & Renee Parsons Coronary and Structural Heart Lab will provide patients with access to innovative procedures and the most advanced technology available.Continue reading
Life Science Nation and Stetson Family Office Join Forces
Launch Collaboration to Provide Early Stage Funding for International Healthcare StartupsContinue reading
National Academy of Inventors names 2 ASU researchers as 2018 Fellows
Arizona State University researchers Joshua LaBaer and Nathan Newman have been named Fellows of the National Academy of Inventors, the organization announced today.Continue reading
Ligand Announces OmniAb® Partnership with iMetabolic Biopharma Corporation
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced on Nov. 21, 2018 that it has entered into a worldwide OmniAb partnership with iMetabolic Biopharma Corporation (iMBP), an early stage biopharma company located in Tempe, AZ.Continue reading